Chordate Medical Holding AB has a quick ratio of 1.54. It generally indicates good short-term financial strength.
The historical rank and industry rank for Chordate Medical Holding AB's Quick Ratio or its related term are showing as below:
OSTO:CMH'
s Quick Ratio Range Over the Past 10 Years
Min: 0.14 Med: 1.57 Max: 5.93
Current: 1.54
During the past 10 years, Chordate Medical Holding AB's highest Quick Ratio was 5.93. The lowest was 0.14. And the median was 1.57.
OSTO:CMH's Quick Ratio is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 1.86
vs OSTO:CMH: 1.54
Chordate Medical Holding AB (OSTO:CMH) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Chordate Medical Holding AB Quick Ratio Related Terms
Chordate Medical Holding AB Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Chordate Medical Holding AB's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chordate Medical Holding AB Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Chordate Medical Holding AB's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Chordate Medical Holding AB's Quick Ratio falls into.
Chordate Medical Holding AB Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chordate Medical Holding AB (OSTO:CMH) has a Quick Ratio of 1.54 as of Jun. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Chordate Medical Holding AB and its competitors. This is near median its historical median of 1.57. Over the past decade, Chordate Medical Holding AB's Quick Ratio has ranged from 0.14 to 5.93.
Is Chordate Medical Holding AB's Quick Ratio too high?
Chordate Medical Holding AB's current Quick Ratio of 1.54 is near median its 10-year median of 1.57. Over the past 10 years, this metric has ranged from a low of 0.14 to a high of 5.93. The Medical Devices & Instruments industry median Quick Ratio is 1.86. Chordate Medical Holding AB's value of 1.54 is 17.2% below this industry median. Overall, Chordate Medical Holding AB has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Chordate Medical Holding AB's Quick Ratio compare to ABT and SYK?
Chordate Medical Holding AB's Quick Ratio of 1.54 can be compared against companies in the Medical Devices & Instruments industry. The industry median Quick Ratio is 1.86. Chordate Medical Holding AB's value of 1.54 is 17.2% below this benchmark. Historically, Chordate Medical Holding AB's own Quick Ratio has ranged from 0.14 to 5.93 over the past decade. While the company's 10-year median is 1.57 vs. the industry median of 1.86, Chordate Medical Holding AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.86, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chordate Medical Holding AB's current Quick Ratio of 1.54 is 17.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Chordate Medical Holding AB and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chordate Medical Holding AB's current Quick Ratio is 1.54, which is near median its own 10-year median of 1.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chordate Medical Holding AB stock overvalued right now?
Chordate Medical Holding AB (OSTO:CMH) has a current Quick Ratio of 1.54. The stock's GF Value™ is kr26.18, compared to a current price of kr0.16 — trading 99.4% below its estimated fair value. The current Quick Ratio is 1.54, which is near median its 10-year median of 1.57 and 17.2% below the Medical Devices & Instruments industry median of 1.86. Chordate Medical Holding AB's overall GF Score™ is 46/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Chordate Medical Holding AB (OSTO:CMH), the current Quick Ratio is 1.54 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chordate Medical Holding AB (OSTO:CMH) Overvalued in 2026?
Based on GuruFocus' analysis, Chordate Medical Holding AB stock appears to be undervalued.
The current stock price of kr0.16 is trading 99.4% below its estimated GF Value™ of kr26.18.
Key valuation signals for OSTO:CMH:
Quick Ratio: 1.54 (near median its 10-year median of 1.57)
GF Value™: kr26.18 vs. price of kr0.16 (99.4% below fair value)
Industry Position: 17.2% below the Medical Devices & Instruments median
No single metric tells the full story. See the OSTO:CMH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chordate Medical Holding AB is a medical technology company that has developed patented and CE-marked a new nerve-modulating treatment technology for chronic nasal congestion and chronic migraine. The company sells its products in Selected European markets, Israel, and Saudi Arabia. The company's product range is based on the CE-marked treatment units Chordate System S100 and S120 for rhinitis and S220 for migraine, registered for the indications of preventive treatment of chronic migraine and chronic rhinitis and use on patients. The company sells its product system, including treatments, through distributors to clinics and hospitals in its primary markets.
46GF Score
Get the complete analysis for OSTO:CMH
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:CMH has been successfully added to your 
